Elsevier

Molecular Therapy Template

Write in a clean editor, then format for Molecular Therapy in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Molecular Therapy format

Molecular Therapy is a peer-reviewed journal published by Elsevier, covering Virus-based gene therapy research, RNA Interference and Gene Delivery, CRISPR and Genetic Engineering.

PublisherElsevier
Reference styleNumbered (Elsevier)
Numbered — [1], [2] in the text
[1] A. Smith, B. Jones, C. Lee, A representative article title, Molecular Therapy 12 (2023) 45–58.

Formats any DOI in Molecular Therapy style. No sign-up.

Publishes research inVirus-based gene therapy research RNA Interference and Gene Delivery CRISPR and Genetic Engineering Viral Infectious Diseases and Gene Expression in Insects CAR-T cell therapy research
ISSN1525-0016
Citation impact (2-yr)6.51
h-index259
i10-index5,511
Total citations469,783
Article processing charge$3,900
Top institutions publishing hereUniversity of Pennsylvania
Journal websitewww.journals.elsevier.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Molecular Therapy per year

1.1K
2014
972
2015
976
2016
355
2017
278
2018
250
2019
331
2020
319
2021
291
2022
289
2023
436
2024
608
2025

Citation impact of Molecular Therapy by publication year

15.5K
2014
15.7K
2015
12.7K
2016
31.3K
2017
19.6K
2018
17.2K
2019
19K
2020
14.7K
2021
11.9K
2022
6.9K
2023
5.2K
2024
3K
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Molecular Therapy

Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2

Richard A. Morgan, James C. Yang, Mio Kitano et al. · 23 Feb 2010

In an attempt to treat cancer patients with ERBB2 overexpressing tumors, we developed a chimeric antigen receptor (CAR) based on the widely used humanized monoclonal antibody (mAb) Trastuzumab (Herceptin). An optimized CAR vector containing CD28, 4-1BB, and CD3zeta signaling moieties was assembled in a gamma-retroviral vector and used to transduce autologous peripheral blood lymphocytes (PBLs)…

2,548 citations Cite SaveGo to paper →
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Katalin Karikó, Hiromi Muramatsu, Frank A. Welsh et al. · 16 Sep 2008

In vitro–transcribed mRNAs encoding physiologically important proteins have considerable potential for therapeutic applications. However, in its present form, mRNA is unfeasible for clinical use because of its labile and immunogenic nature. Here, we investigated whether incorporation of naturally modified nucleotides into transcripts would confer enhanced biological properties to mRNA. We found that mRNAs containing pseudouridines…

1,890 citations Cite SaveGo to paper →
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells

Shin‐ichiro Ohno, Masakatsu Takanashi, Katsuko Sudo et al. · 2 Oct 2012

Despite the therapeutic potential of nucleic acid drugs, their clinical application has been limited in part by a lack of appropriate delivery systems. Exosomes or microvesicles are small endosomally derived vesicles that are secreted by a variety of cell types and tissues. Here, we show that exosomes can efficiently deliver microRNA (miRNA) to epidermal growth…

1,658 citations Cite SaveGo to paper →
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection

Carmela Zincarelli, Stephen Soltys, Giuseppe Rengo et al. · 15 Apr 2008

This study examines transgene expression and biodistribution of adeno-associated virus (AAV) pseudotyped 1–9 after tail vein (TV) injection in male mice. Using a cytomegalovirus (CMV)-luciferase transgene, the time-course of expression in each animal was tracked throughout the experiment. The animals were imaged at 7, 14, 29, 56, and 100 days after the TV injection. The…

1,505 citations Cite SaveGo to paper →

Molecular Therapy template — frequently asked questions

How do I write a paper in the Molecular Therapy format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Molecular Therapy template. When you export, DocuGuru compiles the paper into the official Elsevier format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Molecular Therapy use?
Molecular Therapy uses Numbered (Elsevier) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: [1] A. Smith, B. Jones, C. Lee, A representative article title, Molecular Therapy 12 (2023) 45–58.
Do I need to know LaTeX to submit to Molecular Therapy?
No. DocuGuru generates the elsarticle LaTeX class and compiles the PDF for you in the background, so you get a Elsevier-ready Molecular Therapy document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Molecular Therapy template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Molecular Therapy format with correct headings, figures, tables, and numbered citations.
Who publishes Molecular Therapy?
Molecular Therapy is a multidisciplinary journal published by Elsevier. DocuGuru's Molecular Therapy template matches Elsevier's official submission format.
Can I export a submission-ready Molecular Therapy PDF?
Yes — DocuGuru produces a PDF built with the official Molecular Therapy template (the elsarticle class) that is ready to submit to Elsevier, together with the matching LaTeX source files.
How much does the Molecular Therapy template cost?
You can start writing in the Molecular Therapy template for free. Exporting the final submission-ready Molecular Therapy PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Molecular Therapy template